SCHEDULE 13G/A

Relmada Therapeutics Inc

Common Stock ($.001 par value) · CUSIP: 75955J402

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Squadron Master Fund LP

  Shares: 7,395,510.00 · Class: 9.9%

• Squadron Capital Management LLC

  Shares: 7,395,510.00 · Class: 9.9%

• William Blank

  Shares: 7,395,510.00 · Class: 9.9%

• Matthew Sesterhenn

  Shares: 7,395,510.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.